Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8788 |
High Similarity |
NPD5844 |
Phase 1 |
0.875 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD7228 |
Approved |
0.8462 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8415 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8395 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8383 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD37 |
Approved |
0.8313 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8293 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8293 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8293 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8282 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8263 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8239 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8105 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8105 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8081 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8061 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8023 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8012 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7988 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7977 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7974 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7941 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7931 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7898 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7886 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7843 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7811 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7809 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7758 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD1512 |
Approved |
0.774 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7738 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7736 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7736 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7719 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7716 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7714 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.766 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7657 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7634 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7593 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7576 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7576 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7576 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7546 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7544 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7531 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3226 |
Approved |
0.75 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7461 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7439 |
Intermediate Similarity |
NPD7003 |
Approved |
0.741 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7385 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7381 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7346 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7301 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7296 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7292 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7256 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7256 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7229 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7195 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7188 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD919 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD17 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7119 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7113 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7098 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7098 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7098 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7098 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7097 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7091 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7077 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7077 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7077 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7074 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7074 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7026 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7026 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7026
|
Intermediate Similarity |
NPD7696 |
Phase 3 |